Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: A meta-analysis of ten randomized controlled trials

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 1, 2016, Pages 2-10

  Li, Yanchuan ^a   Wang, Cheng ^a   Huai, Qingjie ^b   Guo, Fuchuan ^a   Liu, Liyan ^a   Feng, Rennan ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Meta analysis; Metabolic profile; T2DM; Tea

Indexed keywords

ADIPONECTIN; BLACK TEA EXTRACT; CHOLESTEROL; CREATININE; GLUCOSE; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; ANOREXIGENIC AGENT; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PLANT EXTRACT; TEA;

BLOOD PRESSURE; BODY MASS; BODY WEIGHT MAINTENANCE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; META ANALYSIS; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TEA; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BLOOD; CAMELLIA SINENSIS; CHEMISTRY; COMPLICATION; DIABETIC DIET; DIET THERAPY; DIETARY SUPPLEMENT; FOOD INTAKE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; LOW CALORY DIET; METABOLISM; OBESITY; PLANT LEAF;

APPETITE DEPRESSANTS; APPETITE REGULATION; CAMELLIA SINENSIS; DIABETES MELLITUS, TYPE 2; DIET, DIABETIC; DIET, REDUCING; DIETARY SUPPLEMENTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; OVERWEIGHT; PLANT EXTRACTS; PLANT LEAVES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84953840253     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2641     Document Type: Review

References (44)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9): 1414-31. [PubMed:9727886].
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2): 137-49. [PubMed:24630390].
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-53.[PubMed:15111519].
4. Robertson R, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys. 2007; 48(2-3): 139-46.[PubMed:17709883].
5. Wright E, Jr., Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006; 60(3): 308-14.[PubMed:16494646].
6. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24(5): 816-23. [PubMed:14976002].
7. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr. 2002; 21(1): 1-13.[PubMed:11838881].
8. Pastore RL, Fratellone P. Potential health benefits of green tea (Camellia sinensis): a narrative review. Explore. 2006; 2(6): 531-9.[PubMed:17113495].
9. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997; 37(8): 693-704. [PubMed:9447270].
10. Yang WS, Wang WY, Fan WY, Deng Q, Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr. 2014; 111(8): 1329-39.[PubMed:24331002].
11. Hayashino Y, Fukuhara S, Okamura T, Tanaka T, Ueshima H, Group H-OR. High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study. Diabet Med. 2011; 28(7): 805-10. [PubMed:21244473].
12. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, et al. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr. 2010; 103(3): 453-9.[PubMed:19818197].
13. Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol. 2002; 83(1-2): 109-16.[PubMed:12413715].
14. Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 2011; 94(2): 601-10.[PubMed:21715508].
15. Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH. Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013; 97(4): 750-62.[PubMed:23426037].
16. Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B, et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care. 2003;26(6): 1714-8.[PubMed:12766099].
17. Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. 2008; 62(8): 953-60.[PubMed:17554248].
18. Nagao T, Meguro S, Hase T, Otsuka K, Komikado M, Tokimitsu I, et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity. 2009; 17(2): 310-7.[PubMed:19008868].
19. Neyestani TR, Shariatzade N, Kalayi A, Gharavi A, Khalaji N, Dadkhah M, et al. Regular daily intake of black tea improves oxidative stress biomarkers and decreases serum C-reactive protein levels in type 2 diabetic patients. Ann Nutr Metab. 2010; 57(1): 40-9.[PubMed:20668372].
20. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Alternative medicine review : a journal of clinical therapeutic. 2011; 16(2): 157-63.[PubMed:21649457].
21. Mousavi A, Vafa M, Neyestani T, Khamseh M, Hoseini F. The effects of green tea consumption on metabolic and anthropometric indices in patients with Type 2 diabetes. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2013; 18(12): 1080-6.[PubMed:24523800].
22. Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One. 2014; 9(3): e91163.[PubMed:24614112].
23. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract. 2006; 71(3): 356-8.[PubMed:16169629].
24. Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism: clinical and experimental. 2007; 56(10): 1340-4. [PubMed:17884442].
25. Mirzaei K, Hossein-Nezhad A, Karimi M, Hosseinzadeh-Attar M, Jafari N, Najmafshar A, et al. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; a double-blind, placebo-controlled clinical trial study. DARU Journal of Pharmaceutical Sciences 2010; 17(Suppl 1): 38-44.
26. Higgins J. Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. 2008.
27. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006; 174(5): 605-14.[PubMed:16931644].
28. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003; 43(1): 89-143.[PubMed:12587987].
29. Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K, et al. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3 T3-L1 cells. Biosci Biotechnol Biochem 2004; 68(11): 2353-9.[PubMed:15564676].
30. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond). 2005; 29(6): 615-23. [PubMed:15738931].
31. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr. 2004; 43(2): 116-24. [PubMed:15083319].
32. Han MK. Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med. 2003; 35(2): 136-9.[PubMed:12754418].
33. Niu Y, Na L, Feng R, Gong L, Zhao Y, Li Q, et al. The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats. Aging Cell. 2013; 12(6): 1041-9. [PubMed:23834676].
34. Yang BT, Dayeh TA, Kirkpatrick CL, Taneera J, Kumar R, Groop L, et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia. 2011; 54(2): 360-7. [PubMed:21104225].
35. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond). 2009; 33(9): 956-61.[PubMed:19597519].
36. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999; 70(6): 1040-5.[PubMed:10584049].
37. Berube-Parent S, Pelletier C, Dore J, Tremblay A. Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr. 2005; 94(3): 432-6. [PubMed:16176615].
38. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. 2008; 27(3): 363-70. [PubMed:18468736].
39. Nantz MP, Rowe CA, Bukowski JF, Percival SS. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition. 2009; 25(2): 147-54. [PubMed:18848434].
40. Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr. 2009; 139(1): 58-62.[PubMed:19056646].
41. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. J Soc Gynecol Investig. 2006; 13(1): 63-8. [PubMed:16378915].
42. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke; a journal of cerebral circulation. 2009; 40(5): 1786-92.[PubMed:19228856].
43. Wang ZM, Zhou B, Wang YS, Gong QY, Wang QM, Yan JJ, et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011; 93(3): 506-15. [PubMed:21248184].
44. Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, et al. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep 2014; 4: 6251. [PubMed:25176280].